Kuvan 500 mg powder for oral solution
Authorisation EU/1/08/481/005 · Biomarin International Limited
- Licence holder
- Biomarin International Limited (all products →)
- Active substance
- Sapropterin hydrochloride
- Dosage form
- Powder for oral solution
- Route of administration
- Oral use
- ATC code
- A16AX07
- First authorised
- 13/07/2017
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Full application (Article 8(3) of Directive No 2001/83/EC)
Sapropterin hydrochloride: supply and approvals
4 authorised products on the HPRA list contain Sapropterin hydrochloride. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 21 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 21 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 21 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
Centralised EU authorisation. This product holds an EU-wide marketing authorisation granted by the European Commission after assessment by the European Medicines Agency, valid in every EU country. Its EU product number is 481. It has been authorised for 9 years (since 13 July 2017). The HPRA list does not say whether it is on sale.
Other medicines with Sapropterin hydrochloride in Ireland
3 other products on the HPRA list contain Sapropterin hydrochloride, from 2 licence holders; 0 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Kuvan 100 mg powder for oral solution | Biomarin International Limited | Centralised EU authorisation | Not stated |
| Sapropterin Dipharma 100 mg Soluble tablet | Dipharma Arzneimittel GmbH | Centralised EU authorisation | Not stated |
| Sapropterin Dipharma 500 mg Powder for oral solution | Dipharma Arzneimittel GmbH | Centralised EU authorisation | Not stated |
The licence holder
Biomarin International Limited holds 13 products on the HPRA list, with 8 different active substances; 0 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 22 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.